This study tests whether adding the immunotherapy drug durvalumab to standard chemotherapy and radiation can help people with limited-stage small cell lung cancer live longer without their cancer growing. About 105 adults with this specific type of lung cancer will receive either…
Phase: PHASE2 • Sponsor: Michael Hopp • Aim: Disease control
Last updated May 26, 2026 11:59 UTC